CareTrust REIT Prices 19.55 Million-Share Forward Sale at $36.00 Per Share
CareTrust REIT (CTRE) sold 19.55M shares via forward agreements at $36.00/share, with a public offering price of $37.50. The deal, totaling ~$733.1M, involves Bank of America and Morgan Stanley. Settlement may dilute shares by Nov 2027, with potential acceleration under certain conditions. The company and key insiders face a 30-day lock-up on new shares.
How this was made

The 30-second read
Why it matters
The disclosed terms allow the company to raise cash quickly but introduce share‑count risk, which can depress the stock until settlement.
Market read
The forward sale is a material financing event that could trigger short‑term price weakness due to dilution concerns.
What to watch
Potential for cash settlement reduces share issuance; forward price adjustments tied to funding rates may limit dilution.
Background
Forward sale agreements are a financing tool where shares are sold in advance, often at a discount, and settled later.
Ticker impact
CareTrust REIT disclosed a forward sale of 19.55 M shares at $36 each, a $733 M dilutive capital raise.
likely downward pressure as investors price in dilution and cash‑flow uncertainty
Large share count and adjustable pricing mechanism create uncertainty; market typically reacts negatively to dilutive offerings.
Market effects
May signal increased financing activity in the REIT sector, prompting peers to reassess capital structures.
US REIT market could see modest sell‑off pressure.
Limited to REIT investors; no broader macro impact.
Counterpoint
If the proceeds fund high‑yielding assets, the long‑term earnings boost could offset dilution.
Key entities
- companyCareTrust REIT, Inc.
US‑listed REIT filing an 8‑K forward sale.
- financial_institutionBank of America, N.A.
Forward sale participant.
- financial_institutionMorgan Stanley & Co. LLC
Forward sale participant.


